Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Malaria Journal
|
January 27, 2019
Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: characterization of the Plasmodium vivax enzyme and inhibitor studies
Kristina Haeussler, Isabell Berneburg, Esther Jortzik, et al.
The FEBS Journal
|
July 23, 2015
Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target
Stacey M Allen, Erin E Lim, Esther Jortzik, et al.
Antioxidants & Redox Signaling
|
February 26, 2015
Antimalarial NADPH-Consuming Redox-Cyclers As Superior Glucose-6-Phosphate Dehydrogenase Deficiency Copycats
Max Bielitza, Didier Belorgey, Katharina Ehrhardt, et al.
Nature Communications
|
February 18, 2017
Arylmethylamino steroids as antiparasitic agents
Reimar Krieg, Esther Jortzik, Alice-Anne Goetz, et al.
Nature Communications
|
July 10, 2019
Author Correction: Arylmethylamino steroids as antiparasitic agents
Reimar Krieg, Esther Jortzik, Alice-Anne Goetz, et al.
Journal of Medicinal Chemistry
|
July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro
Janina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Malaria Journal
|
January 27, 2019
Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: characterization of the Plasmodium vivax enzyme and inhibitor studies
Kristina Haeussler, Isabell Berneburg, Esther Jortzik, et al.
The FEBS Journal
|
July 23, 2015
Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target
Stacey M Allen, Erin E Lim, Esther Jortzik, et al.
Antioxidants & Redox Signaling
|
February 26, 2015
Antimalarial NADPH-Consuming Redox-Cyclers As Superior Glucose-6-Phosphate Dehydrogenase Deficiency Copycats
Max Bielitza, Didier Belorgey, Katharina Ehrhardt, et al.
Nature Communications
|
February 18, 2017
Arylmethylamino steroids as antiparasitic agents
Reimar Krieg, Esther Jortzik, Alice-Anne Goetz, et al.
Nature Communications
|
July 10, 2019
Author Correction: Arylmethylamino steroids as antiparasitic agents
Reimar Krieg, Esther Jortzik, Alice-Anne Goetz, et al.
Journal of Medicinal Chemistry
|
July 21, 2012
Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro
Janina Preuss, Patrick Maloney, Satyamaheshwar Peddibhotla, et al.
Page
of 3